Management Team

Remi Gloeckler

PhD, CMC Advisor

CMC Advisor, Remi Gloeckler, has extensive experience from CMC and Quality Assurance of viral vectors. He has worked for decades in leadership positions at Transgene, and is the founder of Pharmincell. Remi participated in development of several clinical stage drug candidates. He has been supporting TILT’s CMC and development since 2016.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Chairman of the Board

Aino Kalervo

MSc, MS, Chief Business Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

no image

Suvi Sorsa

PhD, Head of Clinical Research

Víctor Cervera-Carrascón

M.Pharm, Head of Immunology

Riikka Havunen

PhD, Head of R&D

Riikka Kalliokoski

Bachelor of Social and Health Care, Lab manager

João Manuel Santos

MSc, Head of Cell Therapy

Tuija Keinonen

PhD, Chief Regulatory Officer